Study to Evaluate the Pharmacokinetics and Metabolism of [14C] CR845 (Difelikefalin) in Patients With End Stage Renal Disease on Hemodialysis and in Healthy Subjects
Clinical trial NCT03947970 · COMPLETED
Trial details
- NCT number
- NCT03947970
- Sponsor
- Cara Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-17
- Primary completion
- 2019-04-06
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.